The Research and Development Team at Peptilogics is responsible for pioneering the discovery and optimization of novel peptide therapeutics using advanced computational methods. They work tirelessly to explore untapped chemical design spaces, ensuring that new potential drugs are not only biologically viable but also scalable for manufacturing. This team leads the charge in developing clinical-stage therapeutics, including their flagship product PLG0206, aimed at addressing critical unmet medical needs such as prosthetic joint infections.
View all